GWM
ACHN

Gupta Wealth Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Gupta Wealth Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$187K Hold
24,176
– – 0.04% 254
2015
Q4 		$261K Hold
24,176
– – 0.07% 207
2015
Q3 		$167K Buy
+24,176
New +$197K 0.04% 271

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Gupta Wealth Management's ACHN Position: Q1 2016 in Review

Gupta Wealth Management held its Achillion Pharmaceuticals (ACHN) position steady in Q1 2016 at 24,176 shares worth $187K. The position accounts for 0.04% of the portfolio, ranked #254.

Gupta Wealth Management first reported a position in ACHN in Q3 2015 and has held it in 3 quarters since. The position peaked at $261K in Q4 2015. 153 funds tracked by Wall St. Rank hold ACHN as of Q1 2016.

  • Gupta Wealth Management held 24,176 shares of Achillion Pharmaceuticals worth $187K as of Q1 2016.
  • Gupta Wealth Management left its Achillion Pharmaceuticals share count unchanged in Q1 2016.
  • Achillion Pharmaceuticals made up 0.04% of Gupta Wealth Management's portfolio in Q1 2016, its #254 holding.
  • Gupta Wealth Management first reported a position in Achillion Pharmaceuticals in Q3 2015 and has held it in 3 quarters since.
  • Gupta Wealth Management's Achillion Pharmaceuticals position peaked at $261K in Q4 2015.
  • 153 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.